Roivant Sciences Ltd. — Director's Dealing 2021

Oct 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2021-10-20

Reporting Person: Pulik Richard (CHIEF FINANCIAL OFFICER)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-20	Stock Option (Right to Buy)	$6.00	A	313419	Acquired	2031-10-19	Common Shares (313419)	Direct

Footnotes

F1: Represents an award of stock options ("Options") to purchase Common Shares with a vesting commencement date of September 28, 2021. Award of Options vests and becomes exercisable as follows: (i) 25% on the one-year anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.